Management of Sickle Cell Crisis
Initiate immediate aggressive pain control with patient-controlled analgesia (PCA) opioids, aggressive hydration (oral preferred, IV if needed), and oxygen therapy to maintain SpO2 above baseline or 96%—whichever is higher—while maintaining normothermia and monitoring for acute chest syndrome. 1, 2, 3
Immediate Pain Management
- Start opioid therapy immediately using PCA for moderate to severe pain, as this shows superior outcomes with lower overall morphine consumption compared to continuous infusion. 3
- Continue any baseline long-acting opioid medications the patient is already taking for chronic pain management—do not discontinue these during the crisis. 1, 3
- Document baseline analgesic use and perform regular pain assessment using validated pain scales. 1, 2
- Avoid the common pitfall of assuming opioid dependency—this is actually rare in sickle cell patients, while opioid sensitivity is more common. 3
Hydration Strategy
- Prioritize oral hydration when possible, as sickle cell patients have impaired urinary concentrating ability and dehydrate easily. 1, 2
- Administer IV fluids only if oral intake is inadequate, with meticulous fluid management and accurate measurement of fluid losses. 1
- Be cautious with IV hydration—while helpful for dehydration, excessive IV fluids can lead to fluid overload, pulmonary edema, increased length of stay, and new oxygen requirements. 4
- Consider using 5% dextrose solution or 5% dextrose in 25% normal saline rather than normal saline alone, as the hyposthenuria in sickle cell disease reduces the ability to excrete sodium loads. 5
Oxygen and Temperature Management
- Document baseline oxygen saturation and monitor continuously until SpO2 is maintained at baseline in room air. 1, 2
- Administer oxygen therapy to keep SpO2 above baseline or 96%, whichever is higher—do not give oxygen to non-hypoxic patients. 1, 2
- Maintain normothermia actively, as hypothermia leads to shivering and peripheral stasis, which increases sickling. 1, 2
- Employ active warming measures if the patient becomes hypothermic. 1
Nausea and Vomiting Management
- Use dopamine receptor antagonists (haloperidol, metoclopramide, prochlorperazine, olanzapine) as first-line therapy for nausea/vomiting. 2, 3
- Add 5-HT3 antagonists (ondansetron) if vomiting persists despite dopamine antagonists. 2, 3
- Add corticosteroids (dexamethasone) if vomiting still persists after the above measures. 2
- Avoid IV diphenhydramine (Benadryl) as routine antiemetic—its sedation can mask early acute chest syndrome, worsen dehydration through anticholinergic effects, and interfere with early mobilization needed to prevent deep vein thrombosis. 3
Infection Prevention and Monitoring
- Obtain blood cultures if fever is present and initiate antibiotics if temperature reaches ≥38.0°C or if there are signs of sepsis. 2
- Administer antibiotic prophylaxis according to protocols, as sickle cell patients are more susceptible to infections. 1
- Maintain a low threshold for suspecting acute chest syndrome, which can be precipitated by infection and may present with gastrointestinal symptoms. 2
Thromboprophylaxis and Mobilization
- Administer thromboprophylaxis to all post-pubertal patients, as they have an increased risk of deep vein thrombosis, with additional precautions for immobilized patients. 1, 2
- Encourage early mobilization when appropriate to prevent thromboembolic complications. 1, 2
Escalation of Care
- Notify the hematology team immediately upon presentation, as sickle cell crisis represents an emergency requiring prompt intervention. 1
- Maintain a low threshold for admission to high dependency or intensive care units for patients with severe symptoms, complications, or prolonged crisis. 1, 2
- Regular assessment by hematology specialists with multidisciplinary care is essential. 1, 2
Special Considerations
- For patients receiving regional anesthesia, perform regular examinations to detect priapism, as altered sensation may prevent them from noticing its presence. 1
- Rule out underlying causes of symptoms including medication-induced effects, severe constipation, gastroparesis, CNS involvement, and intra-abdominal pathology. 2
- Consider blood transfusion only when truly indicated—not routinely for uncomplicated pain crisis. 5, 6